(MedPage Today) — Quetiapine (Seroquel) was more clinically effective than lithium as a first-line augmentation option in treatment-resistant depression and likely was more cost-effective, a pragmatic multicenter clinical trial suggested. Over… Source link : https://www.medpagetoday.com/psychiatry/depression/114840 Author : Publish date : 2025-03-26 19:28:00 Copyright for syndicated content belongs to the linked Source.
The post Quetiapine May Be Better Option Than Lithium for Treatment-Resistant Depression first appeared on News Health.
Author : News Health
Publish date : 2025-03-26 19:28:00
Copyright for syndicated content belongs to the linked Source.